Acorah Software Products - Accounts Production 14.5.601 false true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 11657705 Dr RC Knights iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11657705 2023-03-31 11657705 2024-03-31 11657705 2023-04-01 2024-03-31 11657705 frs-core:CurrentFinancialInstruments 2024-03-31 11657705 frs-core:RevaluationReserve 2023-04-01 2024-03-31 11657705 frs-core:RevaluationReserve 2023-03-31 11657705 frs-core:RevaluationReserve 2024-03-31 11657705 frs-core:ShareCapital 2024-03-31 11657705 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 11657705 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11657705 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 11657705 frs-bus:SmallEntities 2023-04-01 2024-03-31 11657705 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 11657705 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 11657705 frs-core:UnlistedNon-exchangeTraded 2024-03-31 11657705 frs-core:UnlistedNon-exchangeTraded 2023-03-31 11657705 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-03-31 11657705 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11657705 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11657705 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 11657705 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-03-31 11657705 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11657705 frs-bus:Director1 2023-04-01 2024-03-31 11657705 frs-countries:EnglandWales 2023-04-01 2024-03-31 11657705 2022-03-31 11657705 2023-03-31 11657705 2022-04-01 2023-03-31 11657705 frs-core:CurrentFinancialInstruments 2023-03-31 11657705 frs-core:RevaluationReserve 2023-03-31 11657705 frs-core:ShareCapital 2023-03-31 11657705 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31
Registered number: 11657705
RCK (Pathology) Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2024
Unaudited Financial Statements
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 11657705
2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 48,187 45,370
48,187 45,370
CURRENT ASSETS
Cash at bank and in hand 307,714 233,515
307,714 233,515
Creditors: Amounts Falling Due Within One Year 5 (29,562 ) (30,154 )
NET CURRENT ASSETS (LIABILITIES) 278,152 203,361
TOTAL ASSETS LESS CURRENT LIABILITIES 326,339 248,731
NET ASSETS 326,339 248,731
CAPITAL AND RESERVES
Called up share capital 6 100 100
Revaluation reserve 7 (1,819 ) (4,631 )
Profit and Loss Account 328,058 253,262
SHAREHOLDERS' FUNDS 326,339 248,731
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr RC Knights
Director
12/04/2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
RCK (Pathology) Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11657705 . The registered office is 66 Kent Road, Pudsey, West Yorkshire, LS28 9BH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
4. Investments
Unlisted
£
Cost
As at 1 April 2023 45,370
Additions 5
Revaluations 2,812
As at 31 March 2024 48,187
Provision
As at 1 April 2023 -
As at 31 March 2024 -
Net Book Value
As at 31 March 2024 48,187
As at 1 April 2023 45,370
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Corporation tax 22,184 17,225
Accruals and deferred income 870 864
Director's loan account 6,508 12,065
29,562 30,154
6. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
Page 3
Page 4
7. Reserves
Revaluation Reserve
£
As at 1 April 2023 (4,631 )
Transfer to profit and loss 2,812
As at 31 March 2024 (1,819 )
Page 4